Chemotherapy: Failure of bevacizumab in early-stage colon cancer

Daniel J. Sargent

Research output: Contribution to journalArticle

4 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)10-11
Number of pages2
JournalNature Reviews Clinical Oncology
Volume8
Issue number1
DOIs
StatePublished - Jan 1 2011

Fingerprint

Colonic Neoplasms
Drug Therapy
Bevacizumab

ASJC Scopus subject areas

  • Oncology

Cite this

Chemotherapy : Failure of bevacizumab in early-stage colon cancer. / Sargent, Daniel J.

In: Nature Reviews Clinical Oncology, Vol. 8, No. 1, 01.01.2011, p. 10-11.

Research output: Contribution to journalArticle

@article{5aea4bfc785941c0b3e55a4b432cba34,
title = "Chemotherapy: Failure of bevacizumab in early-stage colon cancer",
author = "Sargent, {Daniel J.}",
year = "2011",
month = "1",
day = "1",
doi = "10.1038/nrclinonc.2010.205",
language = "English (US)",
volume = "8",
pages = "10--11",
journal = "Nature Reviews Clinical Oncology",
issn = "1759-4774",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Chemotherapy

T2 - Failure of bevacizumab in early-stage colon cancer

AU - Sargent, Daniel J.

PY - 2011/1/1

Y1 - 2011/1/1

UR - http://www.scopus.com/inward/record.url?scp=85027916910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027916910&partnerID=8YFLogxK

U2 - 10.1038/nrclinonc.2010.205

DO - 10.1038/nrclinonc.2010.205

M3 - Article

AN - SCOPUS:85027916910

VL - 8

SP - 10

EP - 11

JO - Nature Reviews Clinical Oncology

JF - Nature Reviews Clinical Oncology

SN - 1759-4774

IS - 1

ER -